These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1553388)

  • 41. The neuropsychiatric effects of aspartame in normal volunteers.
    Lapierre KA; Greenblatt DJ; Goddard JE; Harmatz JS; Shader RI
    J Clin Pharmacol; 1990 May; 30(5):454-60. PubMed ID: 2347957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Administration of aspartame potentiates pentylenetetrazole- and fluorothyl-induced seizures in mice.
    Pinto JM; Maher TJ
    Neuropharmacology; 1988 Jan; 27(1):51-5. PubMed ID: 3352866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longer period of oral administration of aspartame on cytokine response in Wistar albino rats.
    Choudhary AK; Sheela Devi R
    Endocrinol Nutr; 2015 Mar; 62(3):114-22. PubMed ID: 25681123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biochemical and clinical effects of aspartame in patients with chronic, stable alcoholic liver disease.
    Hertelendy ZI; Mendenhall CL; Rouster SD; Marshall L; Weesner R
    Am J Gastroenterol; 1993 May; 88(5):737-43. PubMed ID: 8480740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of aspartame ingestion on the carbohydrate-induced rise in tryptophan hydroxylation rate in rat brain.
    Fernstrom JD; Fernstrom MH; Grubb PE
    Am J Clin Nutr; 1986 Aug; 44(2):195-205. PubMed ID: 3728356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationships between phenylalanine hydroxylation and plasma aromatic amino acid concentrations in humans.
    Barazzoni R; Zanetti M; Vettore M; Tessari P
    Metabolism; 1998 Jun; 47(6):669-74. PubMed ID: 9627364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of aspartame and carbohydrate administration on human and rat plasma large neutral amino acid levels and rat brain amino acid and monoamine levels.
    Romano M; Casacci F; De Marchi F; Pacei T; Esteve A; Lomuscio G; Mennini T; Salmona M
    J Nutr; 1989 Jan; 119(1):75-81. PubMed ID: 2913236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delayed plasma clearance of phenylalanine and tyrosine in elderly men.
    Rudman D; Abbasi AA; Chaudry F; Mattson DE
    J Am Geriatr Soc; 1991 Jan; 39(1):33-8. PubMed ID: 1898955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of an aspartame loading test for the detection of heterozygotes for classical phenylketonuria.
    Silva LC; Pires RF; Coelho JC; Jardim LB; Giugliani R
    Clin Genet; 1997 Apr; 51(4):231-5. PubMed ID: 9184243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Construction of hybrid peptide synthetases for the production of alpha-l-aspartyl-l-phenylalanine, a precursor for the high-intensity sweetener aspartame.
    Duerfahrt T; Doekel S; Sonke T; Quaedflieg PJ; Marahiel MA
    Eur J Biochem; 2003 Nov; 270(22):4555-63. PubMed ID: 14622284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of aspartame plus monosodium L-glutamate ingestion on plasma and erythrocyte amino acid levels in normal adult subjects fed a high protein meal.
    Stegink LD; Filer LJ; Baker GL
    Am J Clin Nutr; 1982 Dec; 36(6):1145-52. PubMed ID: 7148735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma phenylalanine levels in phenylketonuric heterozygous and normal adults administered aspartame at 34 mg/kg body weight.
    Stegink LD; Koch R; Blaskovics ME; Filer LJ; Baker GL; McDonnell JE
    Toxicology; 1981; 20(1):81-90. PubMed ID: 7268794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Possible neurologic effects of aspartame, a widely used food additive.
    Maher TJ; Wurtman RJ
    Environ Health Perspect; 1987 Nov; 75():53-7. PubMed ID: 3319565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine).
    Trefz F; de Sonneville L; Matthis P; Benninger C; Lanz-Englert B; Bickel H
    Hum Genet; 1994 Apr; 93(4):369-74. PubMed ID: 8168806
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of the soluble peptide gamma-L-glutamyl-L-tyrosine to provide tyrosine in total parenteral nutrition in rats.
    Radmacher PG; Hilton MA; Hilton FK; Duncan SD; Adamkin DH
    JPEN J Parenter Enteral Nutr; 1993; 17(4):337-44. PubMed ID: 8271358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
    Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
    Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Results of loading doses of aspartame by two phenylketonuric (PKU) children compared with two normal children.
    Koch R; Schaeffler G; Shaw NF
    J Toxicol Environ Health; 1976 Nov; 2(2):459-69. PubMed ID: 1011297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of aspartame and phenylalanine on meal-time food intake of humans.
    Anderson GH; Leiter LA
    Appetite; 1988; 11 Suppl 1():48-53. PubMed ID: 3056266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients.
    Pandharipande PP; Morandi A; Adams JR; Girard TD; Thompson JL; Shintani AK; Ely EW
    Intensive Care Med; 2009 Nov; 35(11):1886-92. PubMed ID: 19588122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of effect of aspartame or of L-phenylalanine on photically induced myoclonus in the baboon, Papio papio.
    Meldrum BS; Nanji N; Cornell RG
    Epilepsy Res; 1989; 4(1):1-7. PubMed ID: 2502388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.